Accelerations Inc. will showcase at ASTRO the TheraView EPID, an image-guided radiotherapy (IGRT) cancer treatment verification system, designed by Dutch manufacturer Cablon Medical BV. The TheraView system, designed for the precise needs of radiation therapy, delivers Clinicians an extensive scope of mega-voltage portal imaging and quality assurance features for daily IGRT verification, according to manufacturer.

TheraView Target Check with automated treatment beam shape verification and patient position verification software gives the precision and control Clinicians need for both conventional, image guided and intensity modulated radiation therapy (IMRT).


Additional Content

News | Interventional Radiology

Feb.12, 2026 — The University of South Florida’s Center for Advanced Medical Learning and Simulation (CAMLS), part of ...

Time February 23, 2026
arrow
News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
Subscribe Now